Method for Preventing Chronic Disease

• US 20090018870A1
• Filed: 11/26/2007
• Published: 01/15/2009
• Est. Priority Date: 12/01/2006
• Status: Abandoned Application

• Current Assignee: Joseph Thomas Weishaar
• Original Assignee: Joseph Thomas Weishaar
• Inventors: Weishaar, Joseph Thomas
• Application Number:
  US12/281,259
• Publication Number:
  US 20090018870A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 30/0217 involving input on products or services in exchange for incentives or rewards
• CPC Class Codes: G06Q 40/08 Insurance
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 20/30 relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• CPC Class Codes: G16H 20/60 relating to nutrition control, e.g. diets
• CPC Class Codes: Y10T 436/201666 Carboxylic acid

Abstract

A new method for preventing chronic disease is described. The method comprises the act of using the result of any biometric test for an individual'"'"'s levels of omega-6 or omega-3 fatty acids as an input in any computerized analysis that determines an economic outcome for the tested individual. This outcome will encourage improved health behavior, which will lead to lowered incidence of chronic disease, improved physical and mental health, improved employee performance, and lower health care costs.

Claims

1-20. -20. (canceled)

21. A process for determining a direct economic outcome for an individual given a device comprising a computer with code operable to transform a biometric test result from the individual into the direct economic outcome for the individual;

the process comprising;

(a) obtaining a biometric test result that measures a level of fatty acid within a sample of biological material from the individual, wherein the fatty acid is selected from a group consisting of omega-3 and omega-6;

(b) inputting the biometric test result from the individual into the device; and

(c) collecting the direct economic outcome for the individual from the device;

whereby the determined direct economic outcome collected from the device influences a health behavior of the individual, leading to improved physical and mental health and a lower rate of chronic disease.

22. The process of claim 21 further comprising the steps of:

(a) taking a sample of biological material from the individual; and

,

(b) performing a biometric test on the sample to measure a level of fatty acid.

23. The process of claim 21 wherein the direct economic outcome is an incentive selected from a group consisting of a discount, a higher price, a lower price, and a fee.

24. The process of claim 21 wherein the direct economic outcome is selected from a group consisting of a cost for insurance and an availability of insurance.

25. The process of claim 24 wherein the insurance is health insurance.

26. The process of claim 24 wherein the insurance is life insurance.

27. The process of claim 24 wherein the insurance is disability insurance.

28. The process of claim 24 wherein the insurance is long-term care insurance.

29. The process of claim 21 wherein the direct economic outcome is selected from a group consisting of a cost for health benefits and an availability of health benefits.

30. The process of claim 21 wherein the direct economic outcome is selected from a group consisting of a wellness program incentive and a wellness program disincentive.

31. The process of claim 21 wherein the direct economic outcome is a decision on employment.

32. The process of claim 21 wherein the direct economic outcome is selected from a group consisting of a price for the fatty acid test, a price for a future fatty acid test, and an availability of a future fatty acid test.

33. The process of claim 21 wherein the direct economic outcome is selected from a group consisting of a price for a dietary fatty acid supplement and an availability of a dietary fatty acid supplement.

34. A process for determining a direct economic outcome for an individual given a device comprising a computer with code operable to transform a biometric test result from the individual into the direct economic outcome for the individual;

the process comprising;

(a) obtaining a biometric test result that measures a level of fatty acid within a sample of biological material from the individual, wherein the fatty acid is selected from a group consisting of omega-3 and omega-6;

(b) a step for using the device to determine the direct economic outcome for the individual;

whereby the determined direct economic outcome influences a health behavior of the individual, leading to improved physical and mental health and a lower rate of chronic disease.